Jakrawadee Julamanee

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Hodgkin Lymphoma

Top Venues

Annals of hematology

Asian biomedicine : research, reviews and news

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Thanawat Rattanathammethee, Lalita Norasetthada, Udomsak Bunworasate, Kitsada Wudhikarn, Jakrawadee Julamanee, Panarat Noiperm, Theerin Lanamtieng, Pisa Phiphitaporn, Manassamon Navinpipat, Piyapong Kanya, Dusit Jit-Ueakul, Somchai Wongkhantee, Thanongsak Suwannathen, Juthatip Chaloemwong, Peerapon Wong, Nisa Makruasi, Archrob Khuhapinant, Kannadit Prayongratana, Pimjai Niparuck, Nonglak Kanitsap, Tawatchai Suwanban, Tanin Intragumtornchai
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG). Annals of hematology (2023)
Thareerat Ananchaisarp, Panya Chamroonkiadtikun, Jakrawadee Julamanee, Kewalee Perdvong, Thitawan Chimpalee, Nutnicha Rattanavirakul, Nattawat Leelarujijaroen, Tiprada Hathaipitak, Thanarat Tantinam
Prevalence and management of eosinophilia based on periodic health examinations in primary care clinics. Asian biomedicine : research, reviews and news 16 (5) (2023)
Jirakrit Saetang, Phutthipong Sukkapat, Ajay Mittal, Jakrawadee Julamanee, Wannakorn Khopanlert, Kajornkiat Maneechai, Rasool Abdul Nazeer, Surasak Sangkhathat, Soottawat Benjakul
Proteome Analysis of the Antiproliferative Activity of the Novel Chitooligosaccharide-Gallic Acid Conjugate against the SW620 Colon Cancer Cell Line. Biomedicines 11 (6) (2023)
Jirakrit Saetang, Phutthipong Sukkapat, Ajay Mittal, Jakrawadee Julamanee, Wannakorn Khopanlert, Kajornkiat Maneechai, Rasool Abdul Nazeer, Surasak Sangkhathat, Soottawat Benjakul
Proteome Analysis of the Antiproliferative Activity of the Novel Chitooligosaccharide-Gallic Acid Conjugate against the SW620 Colon Cancer Cell Line. Biomedicines 11 (6) (2023)
Shingo Okuno, Yoshitaka Adachi, Seitaro Terakura, Jakrawadee Julamanee, Toshiyasu Sakai, Koji Umemura, Kotaro Miyao, Tatsunori Goto, Atsushi Murase, Kazuyuki Shimada, Tetsuya Nishida, Makoto Murata, Hitoshi Kiyoi
Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR T Cells. Journal of immunology (Baltimore, Md. : 1950) (2021)